Latest Articles
- In reply: Problems with myocardial infarction definitions
Readers comment on problems with the definition of myocardial infarction (December 2013) and on the diagnosis of myasthenia gravis (November 2013).
- When are effective medications just too expensive?
Physicians may have been taught that it isn’t their job to think about costs—but they should.
- Hepatitis C virus: Here comes all-oral treatment
Direct-acting antiviral drugs open the door for an all-oral regimen, potentially eliminating the need for interferon and thus avoiding its harsh side effects.
- Is hemoglobin A1c an accurate measure of glycemic control in all diabetic patients?
Regard its values with suspicion, especially when they do not agree with the patient’s blood glucose levels.
- Prevention and treatment of influenza in the primary care office
Fewer than half of eligible US residents get vaccinated. Here is a review of the barriers and the new options.
- New practice guidelines: Constrained or enhanced by the evidence?
The new guidelines on cholesterol and hypertension are more evidence-based, but will they help improve outcomes?
- Myasthenia gravis
Readers comment on problems with the definition of myocardial infarction (December 2013) and on the diagnosis of myasthenia gravis (November 2013).
- New hypertension guidelines: One size fits most?
The new report is more evidence-based and focused, outlining a strategy that is simpler and, in some instances, less aggressive.
- In Reply: Stiff, numb hands (June 2013)
Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).
- Stiff, numb hands (June 2013)
Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).